For så vidt angår eksponering som følge af OTC-derivattransaktioner, jf. artikel 52, stk. 2, i direktiv 2009/65/EF, kræver medlemsstaterne, at administrationsselskaberne i beregningen medtager enhver eksponering i forhold til modpartsrisici i forbindelse med OTC-derivater.
With respect to the exposure arising from OTC derivatives transactions as referred to in Article 52(2) of Directive 2009/65/EC, Member States shall require management companies to include in the calculation any exposure to OTC derivative counterparty risk.